- Home
- ADEA vs SLNO Comparison
ADEA vs SLNO Comparison
Compare ADEA & SLNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ADEA | SLNO |
|---|---|---|
| Founded | 1990 | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.0B | 2.3B |
| IPO Year | N/A | 2014 |
Fundamental Metrics
Financial Performance| Metric | ADEA | SLNO |
|---|---|---|
| Price | $19.91 | $43.82 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 4 | 10 |
| Target Price | $22.50 | ★ $112.70 |
| AVG Volume (30 Days) | 975.2K | ★ 1.5M |
| Earning Date | 02-23-2026 | 02-26-2026 |
| Dividend Yield | ★ 1.01% | N/A |
| EPS Growth | ★ 75.65 | N/A |
| EPS | ★ 0.65 | N/A |
| Revenue | ★ $379,912,000.00 | $98,675,000.00 |
| Revenue This Year | $12.15 | N/A |
| Revenue Next Year | N/A | $156.76 |
| P/E Ratio | $30.58 | ★ N/A |
| Revenue Growth | ★ 10.53 | N/A |
| 52 Week Low | $10.59 | $39.43 |
| 52 Week High | $20.16 | $90.32 |
Technical Indicators
Market Signals| Indicator | ADEA | SLNO |
|---|---|---|
| Relative Strength Index (RSI) | 75.65 | 41.27 |
| Support Level | $18.65 | $41.34 |
| Resistance Level | $19.57 | $44.16 |
| Average True Range (ATR) | 0.69 | 2.80 |
| MACD | 0.04 | 0.13 |
| Stochastic Oscillator | 88.09 | 35.28 |
Price Performance
Historical ComparisonAbout ADEA Adeia Inc.
Adeia Inc is a consumer and entertainment product/solutions licensing company. Its only operating segment being Intellectual Property (IP) Licensing. In the IP segment, the company licenses innovations to companies in the broader entertainment industry, and those developing new technologies that will help drive this industry forward. It includes Pay-TV, Consumer Electronics, Connected Car, and Media Platform.
About SLNO Soleno Therapeutics Inc.
Soleno Therapeutics Inc is a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases. Its product candidate DCCR (Diazoxide Choline) Extended-Release tablets, is a proprietary extended-release formulation of a crystalline salt of diazoxide. DCCR has demonstrated the ability to activate the KATP channel in the brain, pancreas, and fat tissue.